792 related articles for article (PubMed ID: 32513136)
1. Single-institutional outcome-analysis of low-dose stereotactic body radiation therapy (SBRT) of adrenal gland metastases.
Voglhuber T; Kessel KA; Oechsner M; Vogel MME; Gschwend JE; Combs SE
BMC Cancer; 2020 Jun; 20(1):536. PubMed ID: 32513136
[TBL] [Abstract][Full Text] [Related]
2. Stereotactic body radiotherapy (SBRT) for adrenal metastases of oligometastatic or oligoprogressive tumor patients.
König L; Häfner MF; Katayama S; Koerber SA; Tonndorf-Martini E; Bernhardt D; von Nettelbladt B; Weykamp F; Hoegen P; Klüter S; Susko MS; Debus J; Hörner-Rieber J
Radiat Oncol; 2020 Feb; 15(1):30. PubMed ID: 32019553
[TBL] [Abstract][Full Text] [Related]
3. Stereotactic body radiotherapy for adrenal oligometastasis in lung cancer patients.
Arcidiacono F; Aristei C; Marchionni A; Italiani M; Fulcheri CPL; Saldi S; Casale M; Ingrosso G; Anselmo P; Maranzano E
Br J Radiol; 2020 Nov; 93(1115):20200645. PubMed ID: 32822540
[TBL] [Abstract][Full Text] [Related]
4. Stereotactic body radiation therapy for adrenal gland metastases: outcome and predictive factors from a multicenter analysis.
Franzese C; Nicosia L; Facondo G; Lo Faro L; Cuccia F; Vullo G; Osti MF; Alongi F; Scorsetti M
Clin Exp Metastasis; 2021 Dec; 38(6):511-518. PubMed ID: 34651241
[TBL] [Abstract][Full Text] [Related]
5. Stereotactic ablative radiotherapy for adrenal gland metastases: Factors influencing outcomes, patterns of failure, and dosimetric thresholds for toxicity.
Chance WW; Nguyen QN; Mehran R; Welsh JW; Gomez DR; Balter P; Komaki R; Liao Z; Chang JY
Pract Radiat Oncol; 2017; 7(3):e195-e203. PubMed ID: 27743801
[TBL] [Abstract][Full Text] [Related]
6. Stereotactic body radiation therapy (SBRT) for treatment of adrenal gland metastases from non-small cell lung cancer.
Holy R; Piroth M; Pinkawa M; Eble MJ
Strahlenther Onkol; 2011 Apr; 187(4):245-51. PubMed ID: 21424513
[TBL] [Abstract][Full Text] [Related]
7. Stereotactic body radiation therapy (SBRT) for patients with oligometastatic/oligoprogressive adrenal metastases: Outcomes and toxicities profile in a monoinstitutional study.
Facondo G; Vullo G; Valeriani M; Ascolese AM; De Sanctis V; Osti MF
Cancer Treat Res Commun; 2021; 29():100481. PubMed ID: 34700142
[TBL] [Abstract][Full Text] [Related]
8. Phase II trial of stereotactic body radiation therapy on adrenal gland metastases: evaluation of efficacy and impact on hormonal production.
Franzese C; Stefanini S; Massaro M; Comito T; Navarria P; Clerici E; Teriaca A; Franceschini D; Reggiori G; Tomatis S; Lania A; Scorsetti M
J Cancer Res Clin Oncol; 2021 Dec; 147(12):3619-3625. PubMed ID: 34537907
[TBL] [Abstract][Full Text] [Related]
9. Stereotactic body radiation therapy (SBRT) in recurrent, persistent or oligometastatic gynecological cancers.
Reshko LB; Baliga S; Crandley EF; Harry Lomas IV; Richardson MK; Spencer K; Bennion N; Mikdachi HE; Irvin W; Kersh CR
Gynecol Oncol; 2020 Dec; 159(3):611-617. PubMed ID: 33059914
[TBL] [Abstract][Full Text] [Related]
10. Single institution experience treating adrenal metastases with stereotactic body radiation therapy.
Shah MM; Isrow D; Fareed MM; Wen N; Ryu S; Ajlouni M; Siddiqui F
J Cancer Res Ther; 2019 Mar; 15(Supplement):S27-S32. PubMed ID: 30900616
[TBL] [Abstract][Full Text] [Related]
11. Early Tolerance and Tumor Control Outcomes with High-dose Ultrahypofractionated Radiation Therapy for Prostate Cancer.
Zelefsky MJ; Pinitpatcharalert A; Kollmeier M; Goldman DA; McBride S; Gorovets D; Zhang Z; Varghese M; Happersett L; Tyagi N; Hunt M
Eur Urol Oncol; 2020 Dec; 3(6):748-755. PubMed ID: 31668713
[TBL] [Abstract][Full Text] [Related]
12. Stereotactic body radiotherapy for treatment of adrenal metastases.
Chawla S; Chen Y; Katz AW; Muhs AG; Philip A; Okunieff P; Milano MT
Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):71-5. PubMed ID: 19250766
[TBL] [Abstract][Full Text] [Related]
13. Long-term local control achieved after hypofractionated stereotactic body radiotherapy for adrenal gland metastases: a retrospective analysis of 34 patients.
Scorsetti M; Alongi F; Filippi AR; Pentimalli S; Navarria P; Clerici E; Castiglioni S; Tozzi A; Reggiori G; Mancosu P; Ricardi U
Acta Oncol; 2012 May; 51(5):618-23. PubMed ID: 22263925
[TBL] [Abstract][Full Text] [Related]
14. Treatment outcomes of metastasis-directed treatment using
Hurmuz P; Onal C; Ozyigit G; Igdem S; Atalar B; Sayan H; Akgun Z; Kurt M; Ozkok HB; Selek U; Oymak E; Tilki B; Guler OC; Mustafayev TZ; Saricanbaz I; Rzazade R; Akyol F
Strahlenther Onkol; 2020 Nov; 196(11):1034-1043. PubMed ID: 32617620
[TBL] [Abstract][Full Text] [Related]
15. Short-term outcomes and clinical efficacy of stereotactic body radiation therapy (SBRT) in treatment of adrenal gland metastases from lung cancer.
Zhao X; Zhu X; Fei J; Ren H; Cao Y; Ju X; Yuan Z; Zhang H
Radiat Oncol; 2018 Oct; 13(1):205. PubMed ID: 30348187
[TBL] [Abstract][Full Text] [Related]
16. Stereotactic Body Radiation Therapy for Mediastinal and Hilar Lymph Node Metastases.
Shahi J; Poon I; Ung YC; Tsao M; Bjarnason GA; Malik NH; Zhang L; Louie AV; Cheung P
Int J Radiat Oncol Biol Phys; 2021 Mar; 109(3):764-774. PubMed ID: 33115687
[TBL] [Abstract][Full Text] [Related]
17. Stereotactic body radiotherapy (SBRT) for medically inoperable lung metastases-A pooled analysis of the German working group "stereotactic radiotherapy".
Rieber J; Streblow J; Uhlmann L; Flentje M; Duma M; Ernst I; Blanck O; Wittig A; Boda-Heggemann J; Krempien R; Lohaus F; Klass ND; Eble MJ; Imhoff D; Kahl H; Petersen C; Gerum S; Henkenberens C; Adebahr S; Hass P; Schrade E; Wendt TG; Hildebrandt G; Andratschke N; Sterzing F; Guckenberger M
Lung Cancer; 2016 Jul; 97():51-8. PubMed ID: 27237028
[TBL] [Abstract][Full Text] [Related]
18. Minimally Invasive Stereotactical Radio-ablation of Adrenal Metastases as an Alternative to Surgery.
Franzese C; Franceschini D; Cozzi L; D'Agostino G; Comito T; De Rose F; Navarria P; Mancosu P; Tomatis S; Fogliata A; Scorsetti M
Cancer Res Treat; 2017 Jan; 49(1):20-28. PubMed ID: 27121718
[TBL] [Abstract][Full Text] [Related]
19. Stereotactic body radiation therapy for curative treatment of adrenal metastases.
Rudra S; Malik R; Ranck MC; Farrey K; Golden DW; Hasselle MD; Weichselbaum RR; Salama JK
Technol Cancer Res Treat; 2013 Jun; 12(3):217-24. PubMed ID: 23369155
[TBL] [Abstract][Full Text] [Related]
20. Radiation-induced brachial plexus toxicity after SBRT of apically located lung lesions.
Lindberg K; Grozman V; Lindberg S; Onjukka E; Lax I; Lewensohn R; Wersäll P
Acta Oncol; 2019 Aug; 58(8):1178-1186. PubMed ID: 31066326
[No Abstract] [Full Text] [Related]
[Next] [New Search]